SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-08-068520
Filing Date
2008-11-06
Accepted
2008-11-06 12:17:22
Documents
2
Period of Report
2008-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a08-25757_28ka.htm 8-K/A 23821
2 EX-99.1 a08-25757_2ex99d1.htm EX-99.1 123333
  Complete submission text file 0001104659-08-068520.txt   148869
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-15006 | Film No.: 081166061
SIC: 2835 In Vitro & In Vivo Diagnostic Substances